Sign In
Section Navigation
Common TitleiPrEx Subgroup Analysis in Transgender Women
Official Title HIV pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial
Phase Phase III
ClinicalTrials.gov NCT00458393
Treatments
Tenofovir DF-Emtricitabine
Tenofovir DF-Emtricitabine Truvada and Multiple Generics

Tenofovir DF-Emtricitabine

Tradename:Truvada and Multiple GenericsOther Names:TDF-FTC, Tenofovir disoproxil fumarate-EmtricitabineClass:Nucleoside Reverse Transcriptase Inhibitors (NRTI)
Categories PREP
Funding
IndustryGilead Sciences
Non-IndustryBill & Melinda Gates Foundation; National Institute of Allergy and Infectious Diseases (NIAID)
References
  • Deutsch MB, Glidden DV, Sevelius J, et al. HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trial. Lancet HIV. 2015;2:e512-9.
    [PubMed Abstract]

Share by e-mail

Since you've received 80% or better on this quiz, you may claim continuing education credit.

You seem to have a popup blocker enabled. If you want to skip this dialog please Always allow popup windows for the online course.